Results 11 to 20 of about 359,694 (255)
In this article, we make a theoretical and in silico study for uncovering and evaluating biomarkers in colon and rectal cancer (CRC) by the dynamic network biomarker (DNB) theory.
Yanqiu Tong +4 more
doaj +1 more source
NDST4 is a novel candidate tumor suppressor gene at chromosome 4q26 and its genetic loss predicts adverse prognosis in colorectal cancer. [PDF]
BACKGROUND: Genomic deletion at tumor suppressor loci is a common genetic aberration in human cancers. The study aimed to explore candidate tumor suppressor genes at chromosome 4q25-q28.2 and to delineate novel prognostic biomarkers associated with ...
Sheng-Tai Tzeng +7 more
doaj +1 more source
Oncogenes and Tumor-Suppressor Genes [PDF]
The functional role of oncogenes in human lung carcinogenesis has been investigated by transfer of activated oncogenes into normal cells or an immortalized bronchial epithelial cell line, BEAS-2B. Transfection of v-Ha-ras, Ki-ras, or the combination of myc and raf into BEAS-2B cells produced tumorigenic cell lines, while transfection of raf or myc ...
T A, Lehman +7 more
openaire +2 more sources
Some facts and thoughts: p73 as a tumor suppressor gene in the network of tumor suppressors
The question of whether p73 is a tumor suppressor gene, is not yet answered with full confidence. The lack of spontaneous tumor formation in p73 null mice and infrequent p73 mutations seen in a variety of cancers analyzed would straightaway negate its ...
Boominathan Lakshmanane
doaj +1 more source
Systematic Analysis of Drug Vulnerabilities Conferred by Tumor Suppressor Loss
Summary: In addition to oncogene inhibition, targeting tumor suppressor deficiency could provide potential venues for precision cancer medicine. However, the full spectrum of drug vulnerability conferred by tumor suppressor loss remains unclear.
Hongyu Ding +11 more
doaj +1 more source
Oncogenes and Tumor Suppressor Genes [PDF]
Breast cancer progression involves multiple genetic events, which can activate dominant-acting oncogenes and disrupt the function of specific tumor suppressor genes. This article describes several key oncogene and tumor suppressor signaling networks that have been implicated in breast cancer progression.
Eva Y H P, Lee, William J, Muller
openaire +2 more sources
Non-small-cell lung cancers (NSCLCs) are largely classified into lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), which have different therapeutic options according to its molecular profiles and immune checkpoint expression, especially
Ahreum Kim +6 more
doaj +1 more source
TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo. [PDF]
We previously reported the identification of TUSC1 (Tumor Suppressor Candidate 1), as a novel intronless gene isolated from a region of homozygous deletion at D9S126 on chromosome 9p in human lung cancer.
Zhihong Shan +5 more
doaj +1 more source
Genetic Changes in Ovarian Cancer
Ovarian cancer is among the most lethal of all malignancies in women. While chemotherapy is the preferred treatment modality, chemoresistance severely limits treatment success.
Kar-San Ling +4 more
doaj +1 more source
Autophagy genes as tumor suppressors [PDF]
Autophagy, originally described as a universal lysosome-dependent bulk degradation of cytoplasmic components upon nutrient deprivation, has since been shown to influence diverse aspects of homeostasis and is implicated in a wide variety of pathological conditions, including cancer.
Chengyu, Liang, Jae U, Jung
openaire +2 more sources

